<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5(1)</volume><submitter>Felix A</submitter><pubmed_abstract>Shortening a pharmacist-driven policy to allow a switch from IV to PO azithromycin after 24 hours instead of 48 hours led to 26% increase in oral azithromycin days of therapy (&lt;i>P&lt;/i> &lt; 0.001) and was associated with a shorter length of stay.</pubmed_abstract><journal>Antimicrobial stewardship &amp; healthcare epidemiology : ASHE</journal><pagination>e65</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11869072</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Single center, retrospective evaluation of requiring 48 hours versus 24 hours before a pharmacist-driven protocol-based IV to PO conversion of azithromycin.</pubmed_title><pmcid>PMC11869072</pmcid><pubmed_authors>Morales L</pubmed_authors><pubmed_authors>Fuerte W</pubmed_authors><pubmed_authors>Felix A</pubmed_authors><pubmed_authors>Gauthier TP</pubmed_authors><pubmed_authors>Pardo W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Single center, retrospective evaluation of requiring 48 hours versus 24 hours before a pharmacist-driven protocol-based IV to PO conversion of azithromycin.</name><description>Shortening a pharmacist-driven policy to allow a switch from IV to PO azithromycin after 24 hours instead of 48 hours led to 26% increase in oral azithromycin days of therapy (&lt;i>P&lt;/i> &lt; 0.001) and was associated with a shorter length of stay.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2025-04-03T23:32:44.389Z</modification><creation>2025-04-03T23:32:44.389Z</creation></dates><accession>S-EPMC11869072</accession><cross_references><pubmed>40026762</pubmed><doi>10.1017/ash.2025.8</doi></cross_references></HashMap>